CME Group Statistics
Total Valuation
CME Group has a market cap or net worth of $71.96 billion. The enterprise value is $73.83 billion.
| Market Cap | 71.96B |
| Enterprise Value | 73.83B |
Important Dates
The next confirmed earnings date is Wednesday, July 24, 2024, before market open.
| Earnings Date | Jul 24, 2024 |
| Ex-Dividend Date | Jun 7, 2024 |
Share Statistics
CME Group has 360.06 million shares outstanding. The number of shares has increased by 0.14% in one year.
| Shares Outstanding | 360.06M |
| Shares Change (YoY) | +0.14% |
| Shares Change (QoQ) | +0.05% |
| Owned by Insiders (%) | 0.43% |
| Owned by Institutions (%) | 90.23% |
| Float | 358.52M |
Valuation Ratios
The trailing PE ratio is 22.74 and the forward PE ratio is 20.36. CME Group's PEG ratio is 8.46.
| PE Ratio | 22.74 |
| Forward PE | 20.36 |
| PS Ratio | 12.79 |
| Forward PS | 11.93 |
| PB Ratio | 2.65 |
| P/FCF Ratio | 21.40 |
| PEG Ratio | 8.46 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.98, with an EV/FCF ratio of 21.95.
| EV / Earnings | 23.38 |
| EV / Sales | 13.12 |
| EV / EBITDA | 15.98 |
| EV / EBIT | 17.29 |
| EV / FCF | 21.95 |
Financial Position
The company has a current ratio of 1.01, with a Debt / Equity ratio of 3.61.
| Current Ratio | 1.01 |
| Quick Ratio | 1.01 |
| Debt / Equity | 3.61 |
| Debt / EBITDA | 21.20 |
| Debt / FCF | 29.11 |
| Interest Coverage | 26.79 |
Financial Efficiency
Return on equity (ROE) is 11.50% and return on invested capital (ROIC) is 2.17%.
| Return on Equity (ROE) | 11.50% |
| Return on Assets (ROA) | 2.30% |
| Return on Capital (ROIC) | 2.17% |
| Revenue Per Employee | $1.58M |
| Profits Per Employee | $885,638 |
| Employee Count | 3,565 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CME Group has paid $912.50 million in taxes.
| Income Tax | 912.50M |
| Effective Tax Rate | 22.42% |
Stock Price Statistics
The stock price has increased by +7.23% in the last 52 weeks. The beta is 0.53, so CME Group's price volatility has been lower than the market average.
| Beta (5Y) | 0.53 |
| 52-Week Price Change | +7.23% |
| 50-Day Moving Average | 201.60 |
| 200-Day Moving Average | 209.13 |
| Relative Strength Index (RSI) | 54.19 |
| Average Volume (20 Days) | 2,859,705 |
Short Selling Information
The latest short interest is 4.51 million, so 1.25% of the outstanding shares have been sold short.
| Short Interest | 4.51M |
| Short Previous Month | 5.96M |
| Short % of Shares Out | 1.25% |
| Short % of Float | 1.26% |
| Short Ratio (days to cover) | 1.78 |
Income Statement
In the last 12 months, CME Group had revenue of $5.63 billion and earned $3.16 billion in profits. Earnings per share was $8.79.
| Revenue | 5.63B |
| Gross Profit | 5.63B |
| Operating Income | 3.48B |
| Pretax Income | 4.11B |
| Net Income | 3.16B |
| EBITDA | 4.62B |
| EBIT | 4.27B |
| Earnings Per Share (EPS) | $8.79 |
Balance Sheet
The company has $96.03 billion in cash and $97.90 billion in debt, giving a net cash position of -$1.87 billion or -$5.19 per share.
| Cash & Cash Equivalents | 96.03B |
| Total Debt | 97.90B |
| Net Cash | -1.87B |
| Net Cash Per Share | -$5.19 |
| Equity (Book Value) | 27.15B |
| Book Value Per Share | 75.42 |
| Working Capital | 1.21B |
Cash Flow
In the last 12 months, operating cash flow was $3.44 billion and capital expenditures -$81.00 million, giving a free cash flow of $3.36 billion.
| Operating Cash Flow | 3.44B |
| Capital Expenditures | -81.00M |
| Free Cash Flow | 3.36B |
| FCF Per Share | $9.36 |
Margins
Gross margin is 100.00%, with operating and profit margins of 61.89% and 56.13%.
| Gross Margin | 100.00% |
| Operating Margin | 61.89% |
| Pretax Margin | 73.07% |
| Profit Margin | 56.13% |
| EBITDA Margin | 82.11% |
| EBIT Margin | 75.90% |
| FCF Margin | 59.79% |
Dividends & Yields
This stock pays an annual dividend of $4.60, which amounts to a dividend yield of 2.30%.
| Dividend Per Share | $4.60 |
| Dividend Yield | 2.30% |
| Dividend Growth (YoY) | 7.14% |
| Years of Dividend Growth | 13 |
| Payout Ratio | 52.33% |
| Buyback Yield | -0.14% |
| Shareholder Yield | 2.16% |
| Earnings Yield | 4.39% |
| FCF Yield | 4.67% |
Analyst Forecast
The average price target for CME Group is $214.85, which is 7.51% higher than the current price. The consensus rating is "Hold".
| Price Target | $214.85 |
| Price Target Difference | 7.51% |
| Analyst Consensus | Hold |
| Analyst Count | 13 |
| Revenue Growth Forecast (5Y) | 4.34% |
| EPS Growth Forecast (5Y) | 5.29% |
Stock Splits
The last stock split was on July 23, 2012. It was a forward split with a ratio of 5:1.
| Last Split Date | Jul 23, 2012 |
| Split Type | Forward |
| Split Ratio | 5:1 |
Scores
CME Group has an Altman Z-Score of 0.62 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.62 |
| Piotroski F-Score | 6 |